EDAP’s Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period

[at noodls] – LYON, France, Feb. 8, 2013 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today new data demonstrating the safety and long-term efficacy of Ablatherm-HIFU, … more

View todays social media effects on EDAP

View the latest stocks trending across Twitter. Click to view dashboard

See who EDAP is hiring next, click here to view